• LOGIN
  • CONTACT US
  • enEnglish (English)
    • deDeutsch (German)
    • esEspañol (Spanish)
    • zh-hans简体中文 (Chinese (Simplified))
    • ja日本語 (Japanese)
    • pt-brPortuguês (Portuguese (Brazil))
    • heעברית (Hebrew)
    • ko한국어 (Korean)
    • frFrançais (French)
Arazy Group Consultants Inc.
  • Regulatory Solutions
    • LICENSALE®
    • REGISLATE®
    • Choose Your Regulatory Solution
    • Cost and Savings
    • European Regulatory Representative Services
  • 140 Countries
  • Resources
  • About Us
    • Webinars
    • Careers
Select Page

The GCC healthcare market series: Qatar

by arazygroup | Apr 21, 2017 | Blog | 0 comments

An Introduction to Qatar

On a peninsula in the Persian Gulf which borders Saudi Arabia lies Qatar, a country roughly as big in size as the US state of Connecticut.

The oil-rich nation, which was under British protection until 1971, has a population of 768, 000, with life expectancy currently at 72 years of age. Ethnicity is diverse with about 40% of the population being made up of Arabs, 46% being made up of Pakistanis, Indians and Iranians , while 14% of the population are from other ethnic backgrounds. The national language is Arabic, but English is widely spoken, with Farsi being spoken by smaller groups in Doha, the country’s capital.

Qatari Healthcare Spending

According to Alpen Capital’s GCC Healthcare Industry report 2016, Qatar recorded the highest per capita healthcare spending (US$ 2,043) in the GCC in 2013. Alpen Capital said a rising population, high disposable income, rising life expectancy, low infant mortality and increasing prevalence of lifestyle diseases such as diabetes and obesity had led to a concurrent increase in the demand for healthcare services. From 2009 to 2013, the total healthcare expenditure in the country had increased at a 15.4% CAGR, reaching US$ 4.4 billion, of which the government financed over 80%. Although the healthcare spending growth in Qatar was the highest in the GCC, it was the lowest as a percentage of the GDP, according to the report. Alpen Capital also stated in the report that the Qatari healthcare market is expected to grow at a CAGR of 12.7% from 2015 to reach US$ 8.8 billion in 2020.

The Supreme Council of Health

Healthcare provision in Qatar is made up of a combination of treatments provided by government health facilities and private medical practices. The country’s Supreme Council of Health (SCH) has the dual mandate to develop policies and programs to improve the people’s health so that they may enjoy longer and more productive lives, and to lay the foundation for a vibrant country for decades to come. The SCH’s goal is to vest responsibility for care in the hands of public institutions and the private sector while regulating, monitoring, and evaluating this care against agreed upon outcomes to ensure that an acceptable quality of care is provided.

Public and private healthcare in Qatar

Qataris have the right to free and equal access to health services, which are financed through central funding from the public budget. However, the government is currently considering an alternative mechanism of healthcare financing through health insurance. Expatriates and tourists can receive free or highly-subsidized healthcare on presentation of a health card.

In 2013, Qatar had a total of 13 hospitals (four of which were private) and 452 primary healthcare centers (419 of which were private). Qatar’s Hamad Medical Corporation (HMC) is a government-run, non-profit healthcare provider that manages eight hospitals as well as the National Ambulance Service and home and residential care services. In January 2016, HMC became the first healthcare system across the world to have all its hospitals accredited by Joint Commission International under the Academic Medical Center accreditation program. Additionally, the National Ambulance Service, Home Healthcare Service, Stroke Service and Palliative Care have all achieved this accreditation. HMC is also the first hospital system in the Middle East to achieve institutional accreditation from the Accreditation Council of Graduate Medical Education – International (ACGME-I), which demonstrates excellence in the way medical graduates are trained through residency, internship and fellowship programs.

Although government healthcare is of a high standard, the private healthcare sector is growing. Private healthcare in Qatar is still relatively cost-effective compared with neighboring regions with highly-developed private healthcare systems.

Medical devices in Qatar

Currently, medical devices do not require registration in Qatar, but they do require an import permit, which must be obtained by a local authorized representative. Furthermore, medical devices must be authorized by one of the founding members of the former Global Harmonization Task Force (GHTF) to obtain market access and must have obtained a Qatar MEC (Ministry of Economy and Commerce) Marketing Authorization before they can be distributed and sold in the country.

D

Search

Recent Posts

  • Malaysia – July 2022
  • Pakistan – July 2022
  • South Africa – June 2022
  • La Technologie des Dispositifs Médicaux
  • The Philippines- June 2022
  • Singapore- April 2022
  • Indonesia- March 2022
  • Malaysia- march 2022
  • The Philippines- Feb 2022
  • Malaysia Update – January 2022

Recent Comments

    Archives

    Categories

    • Application
    • Blog
    • Case Study
    • Documents
    • Homepage
    • Product Demo
    • Product Demo Slider
    • Products
    • Recent Registrations
    • Regulatory News
    • Regulatory News Slider
    • Regulatory Update
    • Regulatory Update Slider
    • Support
    • Top Story Slider
    • Uncategorized
    • Videos

    Arazy Group Consultants Inc. is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets

    Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin

    Regulatory Solutions

    • LICENSALE
    • REGISLATE
    • European Regulatory Representative Services
    • Resources
    • Privacy Policy
    • ISO 9001 Certificate

    Head Office

    #200-1333 Johnston St., Granville Island,
    Vancouver, BC V6H 3R9

    PHONE: +1 604.681.6888
    FAX: +1 604.681.6822
    [email protected]

    © Arazy Group Consultants Inc. - is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets
    ???

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Arazy Group Consultants Inc.
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    Security_overview - Privacy Policy